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INTRODUCTION
Although there is debate about superior vena cava (SVC) 
fi  ltration in patients with upper extremity deep venous 
thrombosis (DVT), a percutaneous SVC fi  lter insertion is 
now regarded as safe, feasible, and effective in preventing 
symptomatic pulmonary embolisms due to upper extremity 
DVT in patients in whom anticoagulation or thrombolysis 
has failed or is contraindicated (1-3). Additionally, a 
retrievable SVC fi  lter can be used as a temporary and 
effective barrier against a symptomatic pulmonary embolism 
in settings where the risk is transient (e.g., after trauma 
or during pregnancy). Such a device is also useful during 
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aggressive, catheter-directed thrombolysis or mechanical 
thrombectomy, which can induce thrombus migration to the 
pulmonary artery (4). 
The Tempofi  lter II (B. Braun, Melsungen, Germany) is a 
kind of temporary caval fi  lter. The cone-shaped fi  lter unit is 
deployed and retrieved using a tethered catheter. The fi  lter 
unit has eight smooth legs and no hooks. The fi  lter cone 
is held in place in the vena cava by a tethering catheter 
with a subcutaneous anchoring device. Most often, the 
Tempofi  lter II is used in the inferior vena cava (IVC) for 
protection against a pulmonary embolism due to lower 
extremity DVT (5). To our knowledge, there are no printed 
reports concerning the placement of the Tempofi  lter II in 
the SVC to prevent a pulmonary embolism in patients with 
upper extremity DVT. In this article, we present a case of 
SVC fi  ltering using the Tempofi  lter II in patients with upper 
extremity DVT.
CASE REPORT
A 67-year-old woman was brought to the emergency unit 
after a traffi  c accident. She suffered multiple traumatic 
injuries including liver laceration, left femoral shaft 
fracture, pelvic bone fractures, and multiple rib fractures. Korean J Radiol 12(1), Jan/Feb 2011 www.kjronline.org 141
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the introducer system (dilator and sheath) was inserted 
along the guide wire into the SVC under fl  uoroscopic 
guidance. After the dilator and guide wire were removed, 
iodinate contrast agent was injected to obtain a superior 
vena cavogram to clarify the exact location of the thrombus 
and to confi  rm the optimal landing zone for a fi  lter in the 
SVC. Next, a fi  lter unit was introduced into the SVC via the 
sheath. By pushing and pulling the tethered catheter, the 
fi  lter was deployed correctly in the supra-azygos SVC. After 
checking the position of the fi  lter, the anchoring device was 
attached to the tethering catheter just around right femoral 
vein, and the excess length of the catheter was sectioned 
immediately above the olive shaped button. After burying 
the anchoring device into the subcutaneous pocket, the 
incision was sutured (Fig. 1D, E). 
After placement of the Tempofi  lter II in the SVC, 
thrombus aspiration was performed through left basilic 
vein with a 100 cm length 8-Fr guiding catheter (Guider 
SofTip; Boston Scientifi  c, Natick, MA). Thrombus aspiration 
via a catheter was performed with a 20 cc syringe. During 
the thrombus aspiration, anticoagulation or thrombolysis 
was not performed. A follow-up venography performed 
after thrombus aspiration showed recanalization of the left 
brachiocephalic vein, regression of collateral veins (Fig. 1F), 
and didn’t show any thrombus capture within the unit. A 
CT angiography obtained two weeks after Tempofi  lter II 
placement demonstrated a patent SVC with no thrombus 
Roughly three weeks later, she developed dyspnea and 
swelling of the left upper extremity. A contrast-enhanced 
chest computed tomography (CT) revealed a pulmonary 
embolism in the right pulmonary artery and thrombosis 
in the left brachiocephalic vein (Fig. 1A, B). On a lower 
extremity CT angiography and Doppler ultrasound taken 
after the diagnosis of pulmonary thromboembolism, 
a lower extremity DVT was not detected. A left upper 
extremity venogram revealed complete obstruction of the 
brachiocephalic vein with lack of collaterals, implying the 
development of acute upper extremity DVT (Fig. 1C). 
To prevent the recurrence of a pulmonary embolism from 
the left upper extremity venous thrombi, and to reduce 
her left arm swelling, removal of venous thrombi was 
necessary. Because anticoagulation and thrombolysis were 
contraindicated due to her recent major trauma history, 
we decided to perform a thrombus aspiration. To prevent a 
further possible pulmonary embolism during the procedure, 
we planned temporary fi  ltration in SVC. 
One day following the diagnosis of upper extremity DVT 
and pulmonary thromboembolism, the Tempofi  lter II was 
placed in the SVC percutaneously, via the right femoral 
vein. After a right femoral vein puncture, a guide wire was 
threaded through the IVC, right atrium, and up into the 
SVC. The subcutaneous puncture site was enlarged by about 
10 mm with an incision and an approximately 20-mm-sized 
subcutaneous pocket was created by tissue dissection. Next, 
AB
Fig. 1. Retrograde tempofi  lter placement within superior vena cava in 67-year-old woman.
A. Contrast enhanced CT shows thrombus in right pulmonary artery (arrow). B. CT scan performed at aortic arch level shows thrombotic total 
occlusion of left brachiocephalic vein (arrows). Note presence of scanty collateral veins around left back area (arrowheads) and bilateral pleural 
effusions. These fi  ndings imply hemothorax after traffi  c accident. Korean J Radiol 12(1), Jan/Feb 2011 www.kjronline.org 142
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around the fi  lter, as well as resolution of the pulmonary 
embolism in the right pulmonary artery. Moreover, no 
additional anticoagulation or thrombolysis was noted. Just 
one day after a follow up CT angiography, we successfully 
removed the fi  lter without complication. Retrieval of the 
fi  lter was achieved by making a skin incision around the 
palpable anchoring device under local anesthesia. The 
tethered catheter and fi  lter were removed by simply pulling 
the tethered catheter outward.
DISCUSSION
The unique design of the Tempofi  lter II consisting of 
a long tethering catheter and fi  lter device with no hook 
is not seen with other fi  lters and because of this, has 
many advantages. First, the Tempofi  lter II is a retrievable, 
temporary fi  lter and this characteristic could make it an 
effective SVC fi  lter. Other advantages of the Tempofi  lter 
II include a long tethering catheter, which makes fi  lter 
retrieval easy and rapid due to the simple traction on the 
tethering catheter. 
EF
Fig. 1. Retrograde tempofi  lter placement within superior vena cava in 67-year-old woman.
C. Left upper extremity venogram shows total occlusion and non-opacifi  cation of left axillary and brachiocephalic veins. There is also refl  ux fl  ow 
at left internal jugular vein (arrows). Note presence of small, collateral vein development. D, E. Radiograms show temporary fi  lter placement in 
superior vena cava. Tethered catheter has caudal direction, and radiopaque subcutaneous anchor is located around right inguinal area. Note fi  lter 
struts without hooks. F. Left upper extremity venogram after mechanical thrombectomy on left brachiocephalic vein shows no residual thrombotic 
occlusion and abnormal collateral veins.
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Yet another advantage is that the Tempofi  lter II is less 
likely to tilt. Its unique design, which has been mentioned 
in the above paragraph, makes it possible that the fi  lter 
possesses a more vertical orientation within the SVC (the 
tethered catheter, which is fi  xed around inguinal area, acts 
like a pendulum). The vertical axis and the lack of tilting 
of the fi  lter within the SVC may increase the ability of the 
fi  lter to capture clots (6). 
Additionally, the Tempofi  lter II has a decreased incidence 
of vena cava injury compared to other fi  lter types, because 
it does not have any hooks on the fi  lter strut. There have 
been several reports about complications related to hooked 
temporary SVC fi  lters, such as SVC perforation, cardiac 
tamponade, and aortic injuries (7-9). 
Finally, the Tempofi  lter II allows for easier optimal fi  lter 
placement. The tethered catheter enables the fi  ne correction 
of fi  lter position by allowing for the movement of the fi  lter 
to-and-fro within the SVC. Usually, placement of a fi  lter at 
the optimal level in the SVC is more technically diffi  cult 
than placement in the IVC, due to the shorter length of the 
optimal landing zone in the SVC (2). 
The use of the Tempofi  lter II in the SVC also has several 
potential limitations or drawbacks. First, the Tempofi  lter 
II cannot be used permanently; it has been validated 
for indwelling times of up to six weeks, although the 
manufacturer states that retrieval is feasible and should 
require no additional equipment, up to three months after 
placement (5). Therefore, if patients need a permanent 
SVC fi  lter, the Tempofi  lter II must be replaced with another 
type of fi  lter device. Second, the Tempofi  lter II should be 
used in only bed-ridden patients. In mobile patients, the 
tethering catheter can bend or buckle due to the effect of 
gravity and the patient’s movement. Furthermore, while the 
lack of hooks on the struts has benefi  ts, this also makes 
the Tempofi  lter II fi  lter more prone to migration within the 
relatively short SVC. In cases where the Tempofi  lter II was 
used in the IVC, there have been reports of intracardiac 
migration inducing fatal outcomes (5, 10). 
A third disadvantage is that the use of the Tempofi  lter 
II is also limited by the length of the introducer sheath 
and the tethered catheter, making it impossible to use the 
Tempofi  lter II in tall patients. When the Tempofi  lter II is 
inserted into the SVC, the tethered catheter is introduced 
through the common femoral vein and travels through the 
iliac vein, IVC, and SVC. As a result, the length of tethered 
catheter remaining outside the body may be insuffi  cient 
to withdraw the introducer sheath up to length of 70 cm. 
However, if the manufacturer were to provide a longer 
tethered catheter, this limit could be easily overcome.
In conclusion, temporary fi  lters should meet two 
important requirements. First, they must be effective for 
several weeks to several months. Second, they must be 
removable from any amount of organized and adherent 
thrombus after anticoagulation therapy has been completed 
and the indication for caval fi  ltration has ceased (5). 
Based on these requirements and despite its drawbacks 
and limitations, the Tempofi  lter II may be one of the good 
options for the temporary fi  ltration of the SVC to prevent 
pulmonary embolisms in bed-ridden patients with upper 
extremity DVTs.
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